StudyFinder

An Observational Study of VYKATTMXR (Diazoxide Choline Extended-Release Tablets) in Patients with Prader-Willi Syndrome (PWS)

Status: Recruiting

This study is collecting information from people with Prader-Willi syndrome (PWS) who are taking VYKAT XR (diazoxide choline extended-release tablets). Researchers will use information from routine medical care to learn more about the long-term safety, treatment experiences, and health outcomes of people treated with VYKAT XR.

I'm interested

Sex: Male or Female
Age Group: Not specified
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• diagnosed with Prader-Willi syndrome (PWS)
• currently taking or planning to start VYKAT XR (diazoxide choline extended-release tablets)
• see link to ClinicalTrials.gov for complete inclusion criteria
Conditions:

Children's Health, Diabetes & Endocrine, Rare Diseases

Keywords:

Children's Health, Prader-Willi syndrome, PWS, Rare Disease

Study Contact: Brad Miller - mille685@umn.edu
Principal Investigator: Brad Miller, MD, PhD
IRB Number: STUDY00028276
See this study on ClinicalTrials.gov

Back